Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion type Assertion NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_head.
- NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_provenance.
- NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion evidence source_evidence_literature NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_provenance.
- NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion SIO_000772 8639762 NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_provenance.
- NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion wasDerivedFrom befree-20140225 NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_provenance.
- NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_assertion wasGeneratedBy ECO_0000203 NP813000.RAebHgfWp1EdXwZzBhFcY7OL89KtE9nQCbE6a8jVWBkwU130_provenance.